These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 12904150)

  • 1. The rational use of potentially hepatotoxic medications in patients with underlying liver disease.
    Lewis JH
    Expert Opin Drug Saf; 2002 Jul; 1(2):159-72. PubMed ID: 12904150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review article: The use of potentially hepatotoxic drugs in patients with liver disease.
    Gupta NK; Lewis JH
    Aliment Pharmacol Ther; 2008 Nov; 28(9):1021-41. PubMed ID: 18671777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review article: drug hepatotoxicity.
    Chang CY; Schiano TD
    Aliment Pharmacol Ther; 2007 May; 25(10):1135-51. PubMed ID: 17451560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review article: prescribing medications in patients with cirrhosis - a practical guide.
    Lewis JH; Stine JG
    Aliment Pharmacol Ther; 2013 Jun; 37(12):1132-56. PubMed ID: 23638982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of potentially hepatotoxic drugs among major US drug compendia.
    Guo JJ; Wigle PR; Lammers K; Vu O
    Res Social Adm Pharm; 2005 Sep; 1(3):460-79. PubMed ID: 17138490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced liver disease.
    Lewis JH; Ahmed M; Shobassy A; Palese C
    Curr Opin Gastroenterol; 2006 May; 22(3):223-33. PubMed ID: 16550036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining patient risks from expanded preventive therapies.
    Tolman KG
    Am J Cardiol; 2000 Jun; 85(12A):15E-9E. PubMed ID: 10858489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Management of adverse effects with antituberculosis chemotherapy].
    Tsuyuguchi K; Wada M
    Kekkaku; 2011 Feb; 86(2):87-99. PubMed ID: 21404653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatic tolerance of atypical antipsychotic drugs].
    Dumortier G; Cabaret W; Stamatiadis L; Saba G; Benadhira R; Rocamora JF; Aubriot-Delmas B; Glikman J; Januel D
    Encephale; 2002; 28(6 Pt 1):542-51. PubMed ID: 12506267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver.
    Piñeiro-Carrero VM; Piñeiro EO
    Pediatrics; 2004 Apr; 113(4 Suppl):1097-106. PubMed ID: 15060205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatotoxic effects of drugs from some pharmacological groups].
    Kinzirskaia IuA; Bogush TA; Ostapchuk NV; Fisenko VP
    Klin Med (Mosk); 2003; 81(10):11-6. PubMed ID: 14664165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury.
    Chen M; Borlak J; Tong W
    Hepatology; 2013 Jul; 58(1):388-96. PubMed ID: 23258593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Methotrexate, liver and rheumatoid arthritis in tropical areas].
    Diouf ML; Diallo S; Mbengue M; Moreira-Diop T
    Sante; 2001; 11(3):195-200. PubMed ID: 11641084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatotoxicity of the thiazolidinediones.
    Tolman KG; Chandramouli J
    Clin Liver Dis; 2003 May; 7(2):369-79, vi. PubMed ID: 12879989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case series of liver failure associated with rosiglitazone and pioglitazone.
    Floyd JS; Barbehenn E; Lurie P; Wolfe SM
    Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1238-43. PubMed ID: 19623674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatotoxicity in patients with liver disease.
    Andreasen PB
    Arch Toxicol Suppl; 1978; (1):131-6. PubMed ID: 277091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting and preventing acute drug-induced liver injury: what's new in 2010?
    Liss G; Rattan S; Lewis JH
    Expert Opin Drug Metab Toxicol; 2010 Sep; 6(9):1047-61. PubMed ID: 20615079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatotoxicity with thiazolidinediones: is it a class effect?
    Scheen AJ
    Drug Saf; 2001; 24(12):873-88. PubMed ID: 11735645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatotoxic effects of drugs in childhood (author's transl)].
    Morlán A; Jara P
    An Esp Pediatr; 1982 Jan; 16(1):66-76. PubMed ID: 7081853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatotoxicity and hepatic metabolism of available drugs: current problems and possible solutions in preclinical stages.
    Giri S; Nieber K; Bader A
    Expert Opin Drug Metab Toxicol; 2010 Aug; 6(8):895-917. PubMed ID: 20367107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.